NCT04281173

Brief Summary

To evulate changes in MfERG, VF and OCT after viterctomy associated with ILM peeling.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2020

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 20, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 24, 2020

Completed
6 days until next milestone

Study Start

First participant enrolled

March 1, 2020

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2021

Completed
Last Updated

February 25, 2020

Status Verified

February 1, 2020

Enrollment Period

1 year

First QC Date

February 20, 2020

Last Update Submit

February 21, 2020

Conditions

Epiretinal Membrane

Outcome Measures

Primary Outcomes (1)

  • BCVA

    after ILM peeling

    6 months

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients with diopathic ERM,Primary full thickness macular hole, Lamellar macular hole, and Vitromacular traction

You may qualify if:

  • Idiopathic ERM,
  • Primary full thickness macular hole,
  • Lamellar macular hole, and
  • Vitromacular traction

You may not qualify if:

  • Patients with a secondary ERM,
  • diabetic retinopathy,
  • venous occlusion,
  • retinal detachment,
  • uveitis, and
  • trauma. 2-Other ocular pathologies that could interfere with the functional results
  • <!-- -->
  • dense cataract ,
  • glaucoma, and
  • previous retinal surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Mensch G. Dental licensing. Midwest Dent. 1968 Oct;44(10):13. No abstract available.

    PMID: 5247634BACKGROUND

MeSH Terms

Conditions

Epiretinal Membrane

Condition Hierarchy (Ancestors)

Retinal DiseasesEye Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
director

Study Record Dates

First Submitted

February 20, 2020

First Posted

February 24, 2020

Study Start

March 1, 2020

Primary Completion

March 1, 2021

Study Completion

June 1, 2021

Last Updated

February 25, 2020

Record last verified: 2020-02